Back to search

Boston University

Elucidating the role of the long noncoding RNA, Gtl2, in rodent models of cardiac disease

Abstract

dc:description.abstract

Recently, the discovery of noncoding RNAs (ncRNAs), such as long noncoding RNAs (lncRNAs) has altered the traditional view of gene regulation. Sequencing of genomes has brought to light the vast stretches of non-protein coding DNA regions that transcribe non-protein coding RNA. LncRNAs are multifunctional and extremely diverse. They can act as signals, decoys, scaffolds, guides, or enhancers. Several lncRNAs, such as Fendrr and Bvht, have been found to have important regulatory functions in cardiac disease and development. The Glt2-Dio3 locus, which is enriched in cardiac muscle, harbors two long intragenic RNAs, MEG3 and MEG8, and harbors one of the largest mammalian miRNA clusters. MEG3, which is termed Gtl2 in rat and mouse, contain 10 exons that are alternatively spliced and give rise to several variants. Gtl2 is conserved across human, rat, and mouse, which makes it an ideal candidate for research and a possible target for therapies. Based on the growing evidence for lncRNAs playing a role in cardiac muscle and our research on the Gtl2-Dio3 microRNAs (miRNAs), I focused on investigating the Gtl2 lncRNA in the heart. Antisense oligonucleotides (GapmeRs) were used to knockdown Gtl2 lncRNA expression levels in cultured, primary neonatal cardiomyocytes in basal and hypertrophic conditions. Although Gtl2 was effectively knocked down in basal conditions I was unable to achieve efficient knockdown in hypertrophic cardiomyocytes induced by phenylephrine treatment. Consequently, I did not observe any modulation of hypertrophy as determined by changes in the expression of Nppa and Nppb, established markers of cardiomyocyte hypertrophy.. Next, I utilized short hairpin RNA (shRNA) to knockdown Gtl2 lncRNA expression levels and obtained robust knockdown. Lastly, I designed a cardiac tropic adeno-associated virus 9 (AAV9) encoding MEG3 DNA for in vivo overexpression experiments as well as an adenovirus encoding MEG3 for in vitro overexpression experiments. These reagents will provide valuable resources for dissecting the functions of the Gtl2 lncRNA. Studies investigating the roles of Gtl2 in the diseased heart my lead to the development of other potential therapies to treat cardiac disease.

Degree

thesis:*
Name thesis:degree_name
M.A.
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Biology
Grantor
Boston University
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hook, Heather

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/24095

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Hook, Heather. Elucidating the role of the long noncoding RNA, Gtl2, in rodent models of cardiac disease. masters thesis, Boston University, 2017. https://hdl.handle.net/2144/24095